Shujie Zhou
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Correction to: TIGIT blockade enhances tumor response to radiotherapy via a CD103 + dendritic cell-dependent mechanism.
Journal: Cancer immunology, immunotherapy : CII
Published: February 22, 2023
Real world practice of postoperative radiotherapy for patients with completely resected pIIIA-N2 non-small cell lung cancer: a national survey of radiation oncologists in China.
Journal: Radiation oncology (London, England)
Published: September 20, 2022
Efficacy and safety of immune checkpoint inhibitors plus anlotinib in small cell lung cancer with brain metastases: a retrospective, multicentre study.
Journal: Journal of neuro-oncology
Published: September 17, 2022
Efficacy of immune checkpoint inhibitor therapy in EGFR mutation-positive patients with NSCLC and brain metastases who have failed EGFR-TKI therapy.
Journal: Frontiers in immunology
Published: May 29, 2022
TIGIT blockade enhances tumor response to radiotherapy via a CD103 + dendritic cell-dependent mechanism.
Journal: Cancer immunology, immunotherapy : CII
Published: November 25, 2021
The landscape of bispecific T cell engager in cancer treatment.
Journal: Biomarker research
Published: January 25, 2021
Berberine downregulates CDC6 and inhibits proliferation via targeting JAK-STAT3 signaling in keratinocytes.
Journal: Cell death & disease
Published: October 23, 2018
Surface passivation engineering strategy to fully-inorganic cubic CsPbI3 perovskites for high-performance solar cells.
Journal: Nature communications
Published: September 24, 2017
Slow-Photon-Effect-Induced Photoelectrical-Conversion Efficiency Enhancement for Carbon-Quantum-Dot-Sensitized Inorganic CsPbBr3 Inverse Opal Perovskite Solar Cells.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: July 02, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026